| 9464072 |
Treatment of central nervous system disorders |
R. Scott Bitner, Kaitlin E. Browman, Yixian Long, Jurgen Dinges, Karla Drescher +17 more |
2016-10-11 |
$171,188,000 |
| 9290444 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
R. Scott Bitner, Kaitlin E. Browman, Steven Fung, Peer B. Jacobson, Lynne E. Rueter +11 more |
2016-03-22 |
$157,995,000 |
| 9133145 |
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
R. Scott Bitner, Kaitlin E. Browman, Steven Fung, Peer B. Jacobson, Lynne E. Rueter +13 more |
2015-09-15 |
$163,445,000 |
| 8993632 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
R. Scott Bitner, Kaitlin E. Browman, Steven Fung, Peer B. Jacobson, Lynne E. Rueter +11 more |
2015-03-31 |
$121,282,000 |
| 8940902 |
Treatment of central nervous system disorders |
R. Scott Bitner, Kaitlin E. Browman, Yixian Chen, Jurgen Dinges, Karla Drescher +17 more |
2015-01-27 |
$84,369,000 |
| 8716345 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
R. Scott Bitner, Kaitlin E. Browman, Steven Fung, Peer B. Jacobson, Lynne E. Rueter +11 more |
2014-05-06 |
$83,603,000 |
| 8415354 |
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
R. Scott Bitner, Kaitlin E. Browman, Steven Fung, Peer B. Jacobson, Lynne E. Rueter +13 more |
2013-04-09 |
$15,948,000 |
| 8198331 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
R. Scott Bitner, Kaitlin E. Browman, Steven Fung, Peer B. Jacobson, Lynne E. Rueter +11 more |
2012-06-12 |
$53,499,000 |
| 7855308 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
Peer B. Jacobson, James T. Link, Jyoti R. Patel, Jeffrey J. Rohde, Qi Shuai +3 more |
2010-12-21 |
$80,581,000 |
| 7737137 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
Peer B. Jacobson, Jeffrey J. Rohde, Jiahong Wang, Steven Fung, Ravi Kurukulasuriya +3 more |
2010-06-15 |
$56,407,000 |
| 7511175 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
Jyoti R. Patel, Qi Shuai, James T. Link, Jeffrey J. Rohde, Jurgen Dinges +4 more |
2009-03-31 |
$127,477,000 |
| 6323231 |
Use of .alpha.1A adrenoceptor agonists with .alpha.1B and .alpha.1D antagonism for the treatment of stress urinary incontinence |
Jorge D. Brioni, Steven Buckner, Teodozyj Kolasa, James P. Sullivan |
2001-11-27 |
$360,874,000 |
